AIDX

0.157113.01%
MS

Michael Saul Lebowitz

Chief Scientific Officer

Dr. Michael Saul Lebowitz, PhD, serves as Chief Scientific Officer at 20/20 Biolabs, Inc. since January 2020. Dr. Lebowitz is the Co-Founder of Ariadne Diagnostics, LLC and serves as its Vice President of Research & Development. Dr. Lebowitz served as a Director of Research and Development at 20/20 GeneSystems, Inc. He served as Director of Research at Panacea Pharmaceuticals, Inc. since 2004, where he was instrumental in the formation of an in-house CLIA-approved laboratory and the launch of three immunoassays for the early detection of cancer and one companion diagnostic, a gene expression-based test to predict the efficacy of a molecular-targeted therapy. He is concurrently chief scientific officer of Athanor Biosciences, Inc., a cancer therapeutics company he cofounded in 2020. Prior to his current positions, he was senior director and vice president of research at Sensei Biotherapeutics from 2014-2019. Dr. Lebowitz joined Panacea Pharmaceuticals in 2000 as a Staff Scientist and then served as Director of Parkinson's Disease Program and Project Leader, HAAH Oncology Therapeutics since 2002. Prior to joining Panacea, Dr. Lebowitz was a Research Scientist at Proteinix Corporation in Gaithersburg, Maryland, where he was involved in the development of compounds for the control of ubiquitin-dependent protein degradation. He served as a Member of Advisory Board at Panacea Global, Inc. Dr. Lebowitz is an Adjunct Lecturer in the Advanced Academic Program in Biotechnology at the Krieger School of Arts and Sciences, JHU. He has published numerous articles and abstracts in the fields of enzymology, cellular immunology, cancer and neurodegenerative disease. He is an Inventor on several patents and a Principal Investigator on several NIH-funded SBIR grants. He completed a three year fellowship in immunology in the Department of Pathology, Division of Immunopathology also at the JHU School of Medicine. Dr. Lebowitz received his PhD from the Johns Hopkins University School of Medicine in Biochemistry, Cellular and Molecular Biology.

Positions